证券代码：603297 证券简称：永新光学 公告编号：2021-078 宁波永新光学股份有限公司 关于参加"宁波辖区2021年度上市公司投资者网上集体接待 日主题活动"的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 为进一步加强宁波辖区上市公司与投资者特别是中小投资者的沟通交流，增 强上市公司的透明度，提升公司治理水平，促进公司规范运作，在宁波证监局指 导下，宁波上市公司协会将联合深圳市全景网络有限公司共同举办"心系投资者 携手共行动"——宁波辖区2021年度上市公司投资者网上集体接待日主题活动。 活动于 2021 年 11 月 18 日下午 15:00-17:00 举 行 ， 平 台 登 陆 地 址 为 ： http://rs.p5w.net。 届时，公司高管人员将参加本次活动，通过网络在线交流形式，就公司治理、 发展战略、经营状况、可持续发展等投资者所关心的问题，与投资者进行"一对 多"形式的沟通与交流。欢迎广大投资者踊跃参与！ 特此公告。 宁波永新光学股份有限公司董事会 2021年11月12日 ...

2021 年第三季度报告 单位：元 币种：人民币 证券代码：603297 证券简称：永新光学 宁波永新光学股份有限公司 2021 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 报表信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 | --- | --- | --- | --- | --- | |------------------------------------------------|----------------|-----------------------------------------|----------------|---------------------------- ...

Financial Performance - The company's operating revenue for the first half of 2021 reached CNY 368,351,439.96, an increase of 48.08% compared to CNY 248,745,414.72 in the same period last year[23] - The net profit attributable to shareholders of the listed company was CNY 163,822,430.07, representing a significant increase of 158.12% from CNY 63,467,654.09 in the previous year[23] - The net profit after deducting non-recurring gains and losses was CNY 74,465,870.86, up 52.18% from CNY 48,933,477.39 in the same period last year[23] - The basic earnings per share for the first half of 2021 was CNY 1.48, a 155.17% increase compared to CNY 0.58 in the previous year[27] - The diluted earnings per share was CNY 1.46, reflecting a 151.72% increase from CNY 0.58 in the same period last year[27] - The weighted average return on net assets increased to 12.22%, up by 6.96 percentage points from 5.26% in the previous year[27] - The total assets of the company at the end of the reporting period were CNY 1,636,108,941.72, an increase of 11.95% compared to CNY 1,461,519,990.41 at the end of the previous year[23] - The net assets attributable to shareholders of the listed company were CNY 1,374,832,213.17, representing a 9.25% increase from CNY 1,258,376,571.97 at the end of the previous year[23] - The net cash flow from operating activities was CNY 34,818,228.03, a decrease of 16.01% compared to CNY 41,455,873.08 in the same period last year[23] Market and Industry Trends - The optical microscope industry is experiencing stable demand, with a significant growth trend in high-end microscopes and automated detection equipment due to advancements in technology and increasing domestic manufacturing capabilities[33] - The barcode scanner market is steadily growing, driven by the rise of e-commerce and industrial automation, with the company being a core optical component supplier for major brands[35] - The automotive market is projected to see a rapid increase in the adoption of camera systems and LiDAR technology, with the autonomous driving LiDAR market expected to reach USD 31.5 billion by 2032, growing at a CAGR of over 50%[38] - The machine vision market in China is expanding rapidly, with a market size exceeding RMB 10 billion, driven by increasing demand across various industries including electronics and automotive manufacturing[39] Technological Innovation and Development - The company has a strong focus on technological innovation, having won the National Technology Invention Second Prize in 2019 for its research on super-resolution optical imaging technology[44] - The company has established a comprehensive technical layout in precision optics and has strong competitive advantages in the development and manufacturing of customized core optical components[44] - The company is recognized as a leading entity in the industry, having participated in the formulation of 89 national and industry standards, and is a champion demonstration enterprise in the optical microscope manufacturing sector[44] - The company has established a research institute in collaboration with Zhejiang University, focusing on advanced optical technology projects[59] - The company completed the development of China's first space fluorescence microscope, which was successfully launched with the "Tianhe" core module[59] Product and Revenue Breakdown - Revenue from microscope products reached 130.49 million yuan, up 21.99%, accounting for 35.42% of total revenue[55] - Optical components business generated 230.52 million yuan, a significant increase of 71.45%, making up 62.58% of total revenue[55] - The company’s optical components in barcode scanning and machine vision saw revenue growth exceeding 70% year-on-year[56] - The company has launched its first laser confocal microscope for sale, with expected small-batch sales in the second half of 2021[56] Strategic Goals and Future Plans - The company aims to achieve a fivefold increase in output value over five years as part of its strategic goals[54] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[186] - The company has initiated new product development and market expansion strategies, although specific details were not disclosed in the financial report[178] Shareholder and Governance Matters - The company approved the implementation of the 2019 restricted stock incentive plan, granting 1.345 million shares to 57 incentive objects on December 30, 2019[94] - The company reported a commitment period from September 10, 2018, to September 9, 2023, during which major shareholders are restricted from transferring their shares[108] - Major shareholders are required to maintain a minimum share price during the lock-up period, with automatic extensions if the stock price falls below the issue price for 20 consecutive trading days[111] - The company has implemented a share transfer limit of 25% of their total holdings per year during their tenure and for six months post-departure[111] - The company has established a management system to improve governance and risk control, aiming for sustainable implementation of internal controls[116] Related Party Transactions - The actual related party transaction amount for the first half of 2021 was 8,177,452.26 RMB[145] - The company has committed to not engaging in any undisclosed related party transactions during the actual controller's tenure[135] - The actual controller has promised to avoid any business dealings with the company that could harm the interests of other shareholders[135] - The company has established a commitment to avoid conflicts of interest in related party transactions[135] Financial Position and Cash Flow - Total assets increased to CNY 1,636,108,941.72 as of June 30, 2021, compared to CNY 1,461,519,990.41 at the end of 2020, reflecting a growth of approximately 12.0%[177] - Current assets totaled CNY 1,181,886,667.32, up from CNY 1,006,199,066.11, representing an increase of about 17.4%[177] - Cash and cash equivalents decreased to CNY 457,489,218.16 from CNY 473,857,562.12, a decline of approximately 3.8%[177] - Total liabilities reached CNY 259,624,555.33, up from CNY 203,143,418.44, which is an increase of about 27.8%[179] - The company's equity attributable to shareholders rose to CNY 1,374,832,213.17 from CNY 1,258,376,571.97, reflecting an increase of approximately 9.2%[179] Compliance and Regulatory Matters - The company has ensured compliance with laws and regulations, maintaining integrity in operations during the reporting period[140] - The company committed to ensuring that the prospectus for the initial public offering (IPO) does not contain false records, misleading statements, or significant omissions, and will bear legal responsibility for any losses incurred by investors due to such issues[126] - The company will actively accept social supervision regarding its commitments made during the IPO process and will issue new commitments if unable to fulfill existing ones due to non-force majeure reasons[128]

Financial Performance - Net profit attributable to shareholders was ¥120,004,372.00, representing a significant increase of 289.45% year-on-year[10]. - Operating revenue for the period was ¥172,392,121.34, reflecting a growth of 39.04% compared to the same period last year[10]. - Basic earnings per share increased to ¥1.10, a rise of 292.86% compared to the previous year[10]. - The weighted average return on equity was 8.32%, an increase of 5.75 percentage points from the previous year[10]. - The company reported a substantial increase in other income, which rose to CNY 16,496,514.18, a 1,499.21% increase from CNY 1,031,539.56 in the previous year[18]. - The net profit for Q1 2021 reached ¥119,816,694.10, compared to ¥30,813,869.50 in Q1 2020, indicating a significant increase of about 288.5%[54]. - The total comprehensive income for Q1 2021 was ¥119,833,047.72, significantly higher than ¥30,848,514.81 in Q1 2020, marking an increase of about 287.5%[54]. Cash Flow - The net cash flow from operating activities amounted to ¥23,789,135.55, up by 10.29% year-on-year[10]. - The net cash flow from investment activities showed a remarkable recovery, moving from CNY -242,696,708.52 to CNY 46,265,950.26[23]. - The cash inflow from operating activities for Q1 2021 was RMB 178,878,597.99, an increase of 13.3% compared to RMB 157,061,216.03 in Q1 2020[62]. - The total cash inflow from investment activities in Q1 2021 was RMB 326,486,484.68, significantly higher than RMB 172,070,256.68 in Q1 2020, marking an increase of 89.9%[64]. - The cash inflow from other investment-related activities in Q1 2021 was RMB 217,675,000.00, compared to RMB 170,000,000.00 in Q1 2020, indicating a growth of 28%[64]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,614,168,999.93, an increase of 10.44% compared to the end of the previous year[10]. - The total liabilities increased to CNY 231,077,941.50 from CNY 203,143,418.44, marking an increase of about 13.7%[46]. - The company's total assets increased to RMB 1,614,168,999.93 as of March 31, 2021, compared to RMB 1,461,519,990.41 at the end of 2020[40]. - Current assets rose to RMB 1,167,607,181.49 from RMB 1,006,199,066.11 year-over-year[38]. - The total current liabilities reached CNY 194,291,268.57, compared to CNY 165,201,471.05, marking an increase of about 17.6%[48]. Shareholder Information - The total number of shareholders at the end of the reporting period was 7,184[13]. - The largest shareholder, Yongxin Optoelectronics Industry Co., Ltd., held 29.15% of the shares[13]. Research and Development - Research and development expenses for Q1 2021 were ¥11,984,650.46, up from ¥10,788,346.27 in Q1 2020, reflecting a growth of approximately 11.1%[54]. Financial Management - The financial expenses decreased significantly, showing a change from CNY -7,254,560.69 to CNY -2,431,038.44, indicating improved financial management[18]. - The tax expenses for Q1 2021 amounted to ¥20,296,645.96, compared to ¥5,808,207.57 in Q1 2020, which is an increase of approximately 249.5%[54]. Land Acquisition - The total compensation amount for land acquisition is set at RMB 106,319,012, with RMB 105,255,821.88 received so far, contributing to a net profit of RMB 79,993,999.13 for Q1 2021[32][31]. - The company has not yet received the remaining compensation of RMB 1,063,190.12, and the board will continue to monitor the progress of this land acquisition[33].

Financial Performance - The company's operating revenue for 2020 was RMB 576,409,916.27, representing a 0.59% increase compared to RMB 573,041,849.40 in 2019[25] - The net profit attributable to shareholders for 2020 was RMB 161,683,777.61, an increase of 16.28% from RMB 139,049,415.42 in 2019[25] - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 94,991,936.14, a decrease of 16.78% compared to RMB 114,145,123.88 in 2019[25] - The net cash flow from operating activities for 2020 was RMB 188,752,935.26, which is a 43.05% increase from RMB 131,951,246.06 in 2019[25] - The net assets attributable to shareholders reached ¥1,258,376,571.97 at the end of 2020, an increase of 11.49% compared to ¥1,128,734,909.04 at the end of 2019[28] - Total assets increased by 15.44% to ¥1,461,519,990.41 in 2020 from ¥1,266,001,426.49 in 2019[28] - Basic earnings per share rose by 16.54% to ¥1.48 in 2020, compared to ¥1.27 in 2019[28] - The company reported a net profit attributable to shareholders of ¥67,197,118.61 in Q4 2020, up from ¥32,653,784.59 in Q2 2020[29] - The net cash flow from operating activities in Q4 2020 was ¥97,867,709.00, significantly higher than ¥21,569,823.77 in Q1 2020[29] - Non-recurring gains and losses totaled ¥66,691,841.47 in 2020, compared to ¥24,904,291.54 in 2019[32] Dividend Distribution - The company plans to distribute a cash dividend of RMB 5.30 per 10 shares, totaling RMB 58,580,900.00 based on a total share capital of 110,530,000 shares as of December 31, 2020[7] - The company does not plan to issue bonus shares or convert capital reserves into share capital for this profit distribution[7] - In 2020, the company distributed cash dividends of RMB 5.30 per 10 shares, totaling RMB 58,580,900, representing 36.23% of the net profit attributable to ordinary shareholders[127] Market Position and Growth - The company has established itself as a leader in the optical microscope industry, providing OEM services to major brands like Nikon and Leica[38] - The company has been recognized as a champion demonstration enterprise in the optical microscope manufacturing sector by the Ministry of Industry and Information Technology in 2020[38] - The company is actively expanding into emerging business areas such as automotive optics, machine vision, and artificial intelligence[38] - The global microscope market is expected to recover gradually after a decline in the first half of 2020 due to the pandemic, with long-term growth driven by increased investment in life sciences research[46] - The barcode scanner market is experiencing stable growth, driven by the rise of e-commerce and industrial automation, with major players like Zebra Technologies and Honeywell dominating the high-end market[49] - The automotive camera market is projected to grow rapidly, with the number of sensors in advanced driver-assistance systems (ADAS) expected to increase from 17 in 2022 to 29 by 2030, indicating a significant shift towards autonomous driving[50] - The machine vision market in China has surpassed 10 billion yuan, driven by increasing demand across various industries, including consumer electronics and automotive manufacturing[51] - The Chinese projection market is expected to see a compound annual growth rate (CAGR) of over 14% from 2019 to 2024, fueled by advancements in smart projectors and new light source technologies[52] Research and Development - The company holds 82 patents, including 18 invention patents, and has received the 2020 Zhejiang Province Standard Innovation Excellent Contribution Award, highlighting its strong R&D capabilities[56] - The company has established partnerships with top universities and research institutions, enhancing its collaborative research and development efforts in optical technology[56] - The company has achieved multiple quality management certifications, including IATF16949 and ISO13485, ensuring compliance with global standards and customer requirements[57] - R&D expenses amounted to CNY 47.29 million, accounting for 8.20% of sales revenue, with a year-on-year increase of 4.16%[69] - The total number of R&D personnel is 189, accounting for 17.14% of the total workforce[92] - The company is committed to enhancing its R&D capabilities, focusing on high-end optical components such as barcode scanning lenses and laser radar[113] Corporate Governance and Compliance - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[9] - The company has not violated decision-making procedures for providing guarantees[9] - The audit report for the company was issued by Tianjian Accounting Firm with a standard unqualified opinion[6] - The company has committed to using the funds raised from the IPO specifically for designated purposes, in compliance with relevant laws and regulations[146] - The company guarantees that its prospectus for the initial public offering does not contain false statements or omissions, taking legal responsibility for its accuracy[155] - The company will ensure that any new business opportunities that may compete with the issuer will be notified in writing and offered to the issuer first[160] - The company will bear all economic compensation responsibilities for any claims or penalties arising from employee social insurance or housing fund issues[164] Shareholder Restrictions and Lock-up Period - The company has committed to not transferring or entrusting the management of its shares for 36 months from the date of its initial public offering, with a lock-up period ending on September 9, 2023[131] - Shareholders are restricted from selling more than 25% of their total shares each year during their tenure, and for six months after leaving their positions[134] - If the company's stock price falls below the issue price for 20 consecutive trading days within six months post-IPO, the lock-up period will automatically extend for at least six months[137] - The company must notify and announce any share reductions three trading days prior to the sale, with proceeds from unannounced sales reverting to the company[138] - The company has established a commitment to maintain share prices above the issue price, with adjustments made for any stock splits or dividends[137] Social Responsibility and Community Engagement - The company donated CNY 830,000 worth of laboratory-grade fluorescence microscopes to hospitals in Hubei during the pandemic[75] - The company actively practices social responsibility while enhancing its competitiveness[197] Future Outlook and Strategic Plans - The company plans to achieve a fivefold increase in output value and efficiency over the next five years as part of its new strategic plan[63] - The company anticipates significant growth opportunities in the mid-to-high-end microscopy market due to increased government investment and policy support in scientific instruments and healthcare[106] - The company aims to achieve a fivefold increase in output value and efficiency over the next five years as part of its "555" development strategy[108] - The company plans to focus on high-end microscopes and optical components, expanding applications in research and medical fields while enhancing product performance and automation[111] Related Party Transactions - The company engaged in related transactions with Nanjing Nikon, including purchasing goods worth approximately 1.99 million RMB and selling goods worth about 1.29 million RMB[187] - The company reported a rental expense of approximately 2.71 million RMB from Nanjing Nikon for leasing[187] - The company’s related transactions with United Scope LLC amounted to approximately 22.31 million RMB in sales[187] - The company has not disclosed any major related party transactions during the reporting period[190] Financial Management - The company utilized a total of RMB 940 million in raised funds and RMB 520 million in self-owned funds for financial products during the reporting period[194] - The company approved the use of up to RMB 28 million of idle raised funds for cash management on August 21, 2020[194] - The company approved the use of up to RMB 25 million of idle self-owned funds for cash management on April 24, 2020[194] - The company approved the use of up to RMB 40 million of idle self-owned funds for cash management on January 12, 2021[194] - The company has not reported any overdue amounts from entrusted financial management products[193] - The company has not engaged in any entrusted loan activities during the reporting period[197]

Financial Performance - Operating income for the first nine months was ¥401,707,245.52, a decrease of 1.37% compared to the same period last year[11]. - Net profit attributable to shareholders of the listed company was ¥94,486,659.00, down 6.14% year-on-year[11]. - Basic earnings per share decreased to ¥0.85, down 7.61% from ¥0.92 in the same period last year[13]. - The weighted average return on net assets was 7.74%, a decrease of 1.69 percentage points compared to the previous year[13]. - Total operating revenue for Q3 2020 was approximately ¥114.08 million, an increase from ¥108.75 million in Q3 2019, representing a growth of about 3.9%[55]. - The net profit for Q3 2020 was approximately ¥26.80 million, compared to ¥34.29 million in Q3 2019, indicating a decrease of about 22%[58]. - The total comprehensive income for Q3 2020 was approximately ¥26.80 million, down from ¥34.29 million in Q3 2019[58]. - The operating profit for Q3 2020 was approximately ¥31.46 million, down from ¥39.52 million in Q3 2019, reflecting a decline of about 20.5%[55]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,316,097,745.85, an increase of 3.96% compared to the end of the previous year[11]. - Net assets attributable to shareholders of the listed company amounted to ¥1,208,851,706.03, reflecting a growth of 7.10% year-on-year[11]. - Total current assets amounted to ¥895,909,027.82, a slight increase from ¥860,299,136.31 year-over-year[30]. - Total liabilities decreased to CNY 107,246,039.82 from CNY 137,266,517.45, reflecting a reduction of about 21.9%[36]. - Current liabilities decreased to CNY 98,736,546.12 from CNY 122,487,057.81, a reduction of approximately 19.4%[36]. - Total assets increased to CNY 1,316,097,745.85, up from CNY 1,266,001,426.49, representing a growth of approximately 3.2%[36]. - Non-current assets totaled CNY 420,188,718.03, compared to CNY 405,702,290.18, reflecting an increase of about 3.5%[36]. - The company reported a total current asset of CNY 796,947,466.60, an increase from CNY 766,423,165.92, indicating a growth of about 4.0%[40]. Cash Flow - The net cash flow from operating activities for the first nine months was ¥90,885,226.26, an increase of 30.45% compared to the previous year[11]. - The net cash flow from financing activities improved by ¥20,102,767.51, decreasing to -¥25,997,232.49 from -¥46,100,000.00 year-over-year, mainly due to increased cash received[26]. - The net cash flow from investing activities was negative at ¥-282,828,596.88, a significant decline from a positive cash flow of ¥25,241,606.77 in the previous year[60]. - Total cash inflow from operating activities reached ¥474,656,060.20, up from ¥444,318,349.87 year-on-year, reflecting a growth of 6.3%[60]. - The company reported a cash and cash equivalents balance of ¥215,649,327.42 at the end of the period, compared to ¥202,806,467.10 at the end of the same period in 2019[62]. Shareholder Information - The total number of shareholders at the end of the reporting period was 7,932[14]. - The largest shareholder, Yongxin Optoelectronics Industry Co., Ltd., held 32,217,250 shares, accounting for 29.15% of the total shares[14]. - Shareholders' equity increased to CNY 1,208,851,706.03 from CNY 1,128,734,909.04, representing a growth of approximately 7.1%[36]. Expenses and Subsidies - Management expenses rose by 57.87% to ¥30,384,250.16 from ¥19,246,950.69 year-over-year, primarily due to the accrual of equity incentive expenses[23]. - Other income increased by 171.89% to ¥14,440,958.14 from ¥5,311,303.13 year-over-year, largely due to government subsidies received[23]. - The company received government subsidies amounting to ¥14,440,958.14 for the first nine months, which are closely related to its normal business operations[13].

Financial Performance - The company's operating revenue for the first half of 2020 was CNY 248,745,414.72, a decrease of 2.27% compared to CNY 254,517,043.99 in the same period last year[22]. - The net profit attributable to shareholders of the listed company was CNY 63,467,654.09, an increase of 10.97% from CNY 57,195,284.34 year-on-year[22]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 48,933,477.39, showing a slight decrease of 0.23% compared to CNY 49,043,995.55 in the previous year[22]. - The net cash flow from operating activities at the end of the reporting period was ¥41,455,873.08, a decrease of 5.61% compared to the previous year's end[25]. - Basic earnings per share for the first half of the year was ¥0.58, representing an increase of 11.54% compared to ¥0.52 in the same period last year[25]. - The company's gross profit margin improved to 22.5% in the first half of 2020, compared to 20.5% in the same period last year[177]. - The company reported a net profit of CNY 55,860,218.31 for the first half of 2020, compared to CNY 56,095,764.62 in the same period of 2019, a decrease of 0.42%[177]. - The total profit for the first half of 2020 was CNY 74,185,696.07, compared to CNY 66,826,723.46 in the same period last year, marking an increase of around 10.18%[181]. Revenue Breakdown - The microscope product line generated revenue of 106.96 million yuan, down 6.08%, accounting for 43.00% of total revenue[56]. - The optical components business saw revenue of 134.45 million yuan, an increase of 1.81%, making up 54.05% of total revenue[56]. - The company reported a total of ¥14,534,176.70 in non-recurring gains and losses, with government subsidies contributing ¥8,714,569.67[26]. - The company's revenue for the reporting period was CNY 248.75 million, a decrease of 2.27% compared to the same period last year[64]. Costs and Expenses - Operating costs decreased by 6.86% year-on-year, amounting to CNY 139.93 million[64]. - Research and development expenses totaled CNY 23.70 million, a year-on-year increase of 36.09%[61]. - Management expenses rose by 62.53% year-on-year, amounting to CNY 20.19 million[67]. - The company's financial expenses showed a significant increase, with interest expenses recorded at CNY 306,517.86 compared to CNY 1,058,030.88 in the previous period[181]. Assets and Liabilities - The total assets of the company as of June 30, 2020, were CNY 1,268,912,060.32, showing a marginal increase from CNY 1,266,001,426.49 at the end of 2019[169]. - The total liabilities decreased from CNY 122,487,057.81 in 2019 to CNY 88,124,859.77 in 2020, indicating a reduction of approximately 28%[169]. - The company's cash and cash equivalents decreased significantly from CNY 435,723,955.83 in 2019 to CNY 183,573,246.70 in 2020, representing a decline of approximately 57.8%[165]. - The accounts payable decreased from CNY 73,189,849.32 in 2019 to CNY 54,750,796.00 in 2020, a decrease of about 25%[169]. Market Position and Strategy - The company is a leading supplier of optical precision instruments and components in China, focusing on R&D, production, and sales of optical microscopes and components[30]. - The company has established long-term OEM partnerships with international brands such as Nikon and Leica, enhancing its market position[31]. - The company is actively expanding into emerging business areas such as automotive optics, machine vision, and artificial intelligence[31]. - The company has emphasized the importance of continuous technological innovation to maintain its competitive edge in the optical products market[79]. Shareholder Commitments and Governance - The company has committed to not transferring or managing its shares for 36 months post-IPO, with specific conditions for share reduction thereafter[93]. - The company will ensure that the funds raised from the IPO are used specifically for designated projects, adhering to regulatory requirements[107]. - The company will improve its governance structure to protect shareholders' rights and ensure effective decision-making by the board[111]. - The controlling shareholders have committed not to interfere with the company's management or infringe on its interests[111]. Risks and Compliance - The company has described potential risks in the report, urging investors to pay attention[8]. - The company is currently undergoing a review for re-certification as a high-tech enterprise, which could impact its preferential tax rate if not approved[85]. - The company has committed to ensuring that the prospectus for its initial public offering (IPO) does not contain false records, misleading statements, or significant omissions, and will bear legal responsibility for its authenticity, accuracy, and completeness[114].

Financial Performance - The company's operating revenue for 2019 was RMB 573,041,849.40, an increase of 2.09% compared to RMB 561,286,304.50 in 2018[28]. - The net profit attributable to shareholders for 2019 was RMB 139,049,415.42, representing a growth of 14.12% from RMB 121,842,641.40 in the previous year[28]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 114,145,123.88, up by 9.91% from RMB 103,851,077.17 in 2018[28]. - The net cash flow from operating activities for 2019 was RMB 131,951,246.06, an increase of 17.78% compared to RMB 112,030,441.87 in 2018[28]. - The total assets at the end of 2019 were RMB 1,266,001,426.49, reflecting a 9.14% increase from RMB 1,160,007,746.02 at the end of 2018[28]. - The net assets attributable to shareholders at the end of 2019 were RMB 1,128,734,909.04, which is a 9.64% increase from RMB 1,029,470,491.36 at the end of 2018[28]. - Basic earnings per share for 2019 was CNY 1.27, a decrease of 2.31% compared to 2018[30]. - The weighted average return on equity decreased to 12.93% in 2019, down 7.06 percentage points from 2018[30]. - The gross margin for the main business was 40.78%, reflecting a year-on-year increase of 2.01%[65]. - The company reported a net profit of CNY 24,904,291.54 from non-recurring gains in 2019, compared to CNY 17,991,564.23 in 2018[34]. Dividend Distribution - The company plans to distribute a cash dividend of RMB 4.40 per 10 shares, totaling RMB 48,639,800.00 for the year 2019[7]. - In 2019, the company distributed a cash dividend of 4.40 RMB per 10 shares, totaling 48,639,800 RMB, which represents 34.98% of the net profit attributable to ordinary shareholders[132]. - The cash dividend distribution ratio has shown a slight increase from 34.47% in 2018 to 34.98% in 2019[132]. - The company maintained a consistent dividend policy over the past three years, with no stock bonuses issued[132]. Research and Development - R&D investment reached 45.4 million yuan, accounting for 7.92% of total revenue, with 19 patents obtained and 24 patent applications submitted[75]. - The company has established a strong R&D team and is positioned at an advanced level domestically in production technology and product performance[124]. - Research and development expenses accounted for 8% of total revenue, with a focus on new optical technologies and product innovations[171]. - The company has committed to transparency in its financial reporting and has established a robust internal control system to mitigate risks[179]. Market Expansion and Strategy - The company is actively expanding into emerging business areas such as automotive optics, machine vision, and artificial intelligence[40]. - The company plans to enhance its optical component business towards modularization and scale, focusing on high-end clients and core optical components[118]. - The company aims to achieve high-end microscope domestic substitution and expand into automated and AI-embedded microscope equipment[115]. - The company plans to expand its market presence in Southeast Asia, targeting a 20% increase in market share over the next two years[171]. Risk Management - The company has identified potential risks in its operations, which are detailed in the report[9]. - The company faces risks related to exchange rate fluctuations, as its overseas clients primarily settle in USD, while its reporting currency is RMB[125]. - The company has identified potential risks from the ongoing global pandemic affecting its main export markets, which could impact its sales and supply chain[126]. Corporate Governance - The company has established a sound corporate governance structure and internal control system to protect shareholders' rights[199]. - The company emphasizes the importance of equal rights for all shareholders, particularly minority shareholders, in its governance practices[199]. - The company has committed to enhancing internal control management and improving operational efficiency to mitigate the dilution of immediate returns from the initial public offering[152]. - The company will ensure that any share reduction complies with the laws and regulations of the securities market[149]. Operational Performance - The company has established collaborations with Zhejiang University for advanced research and development, enhancing its technological capabilities and market competitiveness[57]. - The company has a comprehensive technical layout in precision optics and has developed key technologies in high-end microscopy systems[39]. - The company has a strong competitive advantage in optical precision manufacturing, with a history of over 10 years in technology R&D and a total of 77 patents, including 13 invention patents[57]. - The company has built a robust information management platform to streamline production processes, enhancing efficiency and product quality[58]. Compliance and Auditing - The company has maintained compliance with all regulatory requirements, ensuring no penalties or sanctions were imposed during the reporting period[179]. - The company has engaged Tianjian Accounting Firm for auditing services, with a fee of RMB 700,000 for the fiscal year 2019[178]. - The company has not reported any impairment provisions for entrusted financial management or loans during the reporting period[197]. Shareholder Commitments - The company has committed to not transferring or managing shares held prior to the IPO for a period of 36 months from the date of listing[137]. - The company will comply with the relevant regulations of the China Securities Regulatory Commission and the Shanghai Stock Exchange regarding share reduction by shareholders and senior management[146]. - The company will take necessary actions to repurchase shares if any false statements or significant omissions are identified in the prospectus[158]. - The company will publicly explain any failure to fulfill commitments at shareholder meetings and designated media, and will apologize to shareholders and the public[164].

Financial Performance - Net profit attributable to shareholders increased by 19.38% to CNY 30,813,869.50 year-on-year[11] - Operating income rose by 5.20% to CNY 123,989,640.21 compared to the same period last year[11] - Basic earnings per share increased by 16.67% to CNY 0.28[11] - Total operating revenue for Q1 2020 was CNY 123,989,640.21, an increase of 5.4% compared to CNY 117,861,502.07 in Q1 2019[43] - Net profit for Q1 2020 was CNY 30,813,869.50, up 19.4% from CNY 25,811,322.44 in Q1 2019[45] - Operating profit for Q1 2020 reached CNY 29,800,324.52, up 28.5% from CNY 23,216,758.84 in Q1 2019[49] - Total comprehensive income for Q1 2020 was CNY 25,212,314.77, compared to CNY 20,295,006.87 in Q1 2019[51] Cash Flow - Net cash flow from operating activities surged by 100.87% to CNY 21,569,823.77 compared to the previous year[11] - Cash flow from operating activities for Q1 2020 was CNY 21,569,823.77, compared to CNY 10,738,319.47 in Q1 2019, indicating a significant improvement[55] - In Q1 2020, the company reported a net cash flow from operating activities of CNY 34,940,715.90, a significant increase from CNY 3,595,603.51 in Q1 2019, representing a growth of approximately 871%[57] - The total cash inflow from operating activities was CNY 133,395,897.43, compared to CNY 95,899,312.25 in the same period last year, indicating a year-over-year increase of about 39%[57] - The company reported a net cash flow from investment activities of CNY -242,696,708.52 in Q1 2020, contrasting with CNY 10,488,811.50 in Q1 2019[55] - The company experienced a net cash outflow from investing activities of CNY 233,184,987.53, contrasting with a net inflow of CNY 13,716,372.52 in Q1 2019, highlighting a significant shift in investment strategy[59] Assets and Liabilities - Total assets increased by 2.02% to CNY 1,291,551,681.43 compared to the end of the previous year[11] - Total current assets increased to ¥879,436,950.47 from ¥860,299,136.31 year-over-year[28] - Non-current assets totaled ¥412,114,730.96, slightly up from ¥405,702,290.18, indicating a 1.0% increase[31] - Total liabilities decreased to ¥105,652,858.41 from ¥137,266,517.45, a decline of about 23.0%[33] - Shareholders' equity rose to ¥1,185,898,823.02 from ¥1,128,734,909.04, an increase of approximately 5.1%[33] Expenses - Management expenses rose by 60.73% to ¥9,468,754.47 from ¥5,891,052.61 year-over-year[23] - R&D expenses increased by 35.92% to ¥10,788,346.27 from ¥7,937,082.81 year-over-year[23] - Research and development expenses increased to CNY 10,788,346.27, up 36.5% from CNY 7,937,082.81 in Q1 2019[43] Shareholder Information - The total number of shareholders at the end of the reporting period was 8,454[17] - The largest shareholder, Yongxin Optoelectronics Industry Co., Ltd., holds 29.14% of the shares[17] Government Support - The company received government subsidies amounting to CNY 2,294,572.23 during the reporting period[15] Other Financial Metrics - The weighted average return on net assets increased by 0.09 percentage points to 2.57%[11] - The company reported a credit impairment loss of ¥498,329.26, a significant increase compared to a loss of -¥36,553.51 in the previous year[23] - Other comprehensive income after tax was CNY 34,645.31, compared to a loss of CNY 95,991.30 in Q1 2019[45] - The company achieved a gross profit margin of approximately 26.0% in Q1 2020, compared to 19.0% in Q1 2019[43] Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[45] Changes in Financial Reporting - The company has adopted new revenue and leasing standards starting January 1, 2020, which may affect future financial reporting and performance metrics[60]

2019 年第三季度报告 公司代码：603297 公司简称：永新光学 宁波永新光学股份有限公司 2019 年第三季度报告 1 / 26 2019 年第三季度报告 一、 重要提示 二、 公司基本情况. 11[ 重要事项 四、 附录 目录 2 / 26 2019 年第三季度报告 单位：元 币种：人民币 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 1.3 公司负责人曹其东、主管会计工作负责人毛凤莉及会计机构负责人（会计主管人员）毛凤莉 保证季度报告中财务报表的真实、准确、完整。 1.4 本公司第三季度报告未经审计。 二、 公司基本情况 2.1 主要财务数据 | --- | --- | --- | --- | --- | |------------------------------------------------|------------------------------|------------------------------- ...